We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Biofutures | LSE:BIP | London | Ordinary Share | GB00B12B4T47 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 7.025 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From May 2019 to May 2024
TIDMBIP
RNS Number : 2517N
Biofutures International plc
27 September 2012
Biofutures International plc
("Biofutures" or the "Group")
Half Yearly Results for the six months ended 30 June 2012
The Board of Biofutures announces the unaudited interim results of the Company for the period from 1 January 2012 to 30 June 2012. A copy of these financial statements will also be available on the Company's website www.biofuturesplc.com.
For further information, please contact:
Biofutures International plc Tel: + 603 6203 5136 Joe Wong, Chief Executive Officer www.biofuturesplc.com Daniel Stewart & Company plc Tel: + 44 (0) 20 7776 6550 Antony Legge / James Thomas (Nomad) Colin Rowbury (Broker) www.danielstewart.co.uk
CHAIRMAN'S STATEMENT
I am pleased to present our unaudited interim results for the six months ended 30 June 2012.
Financial Review:
Revenue for the 6 month period ended 30 June 2012 was GBP300,000 compared to GBP38,000 for the same period in 2011, reflecting the increased level of operations. However, revenues were down compared to the second half (H2) of 2012 (GBP632,000) as the company suffered from high crude palm oil prices in Malaysia, along with the rest of the Malaysian palm oil industry. Gross margins remained in negative territory, continuing the performance experienced in H2 2011. Operating costs were up year on year to GBP562,000 (H1 2011: GBP307,000) but down on H2 2011 (GBP818,000) as the Company took steps to control its cost base. In previous years, the interest charge had been capitalised whilst the plant was being constructed. With the plant now in full operation, these interim results include financing charges of GBP274,000 in respect of the loan with Bank Kerjasama Rakyat Malaysia Bhd. The result is that the loss for the 6 month period ended 30 June 2012 was GBP839,000 compared to GBP245,000 for the same period in 2011.
A revolving credit facility of RM7.5 million was obtained from Bank Rakyat on 8 June 2012 for the purposes of working capital for the purchase of crude palm oil. To date, this facility has not been utilised.
In February 2012, the Group received the results of the arbitration entered into by Zurex Corporation Sdn Bhd ("Zurex") and JJ Lurgi Engineering Sdn Bhd ("Lurgi"), in relation to a contract dated 26 January 2007 for the supply by Lurgi of components for the construction of a biodiesel plant (the "Contract"). The arbitrator concluded that the contract between Zurex and Lurgi was not terminated and, as a consequence, dismissed the claims by both parties with each side paying its own costs. The directors of Biofutures were disappointed by the outcome, particularly as the Group had received legal advice that its case would be successful. However, because the value of the assets under the Contract has been impaired in prior years, there is no further liability arising as a consequence of the arbitrator's conclusion, and so the decision did not have any material effects on the Group's results.
The dispute with Lurgi was finalised in July, when Zurex agreed to pay Lurgi RM0.8m (GBP0.161m) [GBPGBP 1 = RM4.97], and in return received a high-pressure boiler and 4 pumps, with the payment being spread over 12 months.
In March 2012, our Executive Chairman Mr David Yeoh resigned for personal reasons, and Dr Patrick Howes was appointed as Non-Executive Chairman.
Outlook
According to a report dated 4 September 2012 by one of the leading players in the market (http://www.iffcofatsandoils.com/market_trends.asp?market_id=3) the current refining margin for crude palm oil to refined olein is ca. USD -13 (GBP-8.18) per metric tonne (pmt) in Malaysia, and approximately USD +42 (GBP26.43) pmt in Indonesia, a difference of approximately USD 55 pmt (GBP34.61 ) [US$ 1.5890 = GBPGBP1 www.fx-rate.net].
With the crude palm oil prices in Malaysia being significantly higher than those in neighbouring Indonesia, the palm-oil refining industry in Malaysia has experienced what is probably the toughest period in its history. Whilst Plantation backed refinery groups have been able to maintain much of their market share, with the plantations absorbing losses at the refinery, and multi-national groups have maintained both their market share and profitability by exporting from their Indonesian refineries; Malaysian refiners that are not plantation backed, such as Biofutures, have experienced a loss of market share in the global market.
It is expected that the relatively high crude palm oil price will remain at least until the forthcoming Malaysian General Election, which is now expected to be held in November 2012, and must be held by April 2013 at the latest. Thereafter, government action is expected to restore the profitability of the Malaysian refining industry.
We believe that with a fully functional refinery and the recently completed pipelines between the Zurex refinery and the jetty at POIC Lahad Datu, the Group is well placed to take advantage of export opportunities and generate profits as soon as the current relatively high price of crude palm oil within Malaysia is corrected.
The impact on the carrying value of the property plant and equipment and related intangible assets is being closely monitored, but the directors are of the opinion that no impairment further to that made in the 31 December 2011 accounts is required at this stage.
We continue to search for a suitable partner to assist in the provision of mutual and consistent profitability.
Dr Patrick Howes Non-Executive Chairman
27(th) September 2012
CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME
Hot Features
Premium
Note Six months Six months Year
ended ended ended
30 June 30 June 31 December
2012 2011 2011
(unaudited) (unaudited) (audited)
GBP'000s GBP'000s GBP'000s
Continuing operations
Revenue 300 38 670
Cost of sales (345) (23) (769)
Gross profit/(loss) (45) 15 (99)
Administrative expenses (562) (307) (1,125)
Exceptional items - - (12,480)
Operating loss (607) (292) (13,704)
Finance costs (274) - (223)
Finance income 42 47 80
Loss before tax (839) (245) (13,847)
Income tax 3 - - 1,249
Loss for the period/year attributable
to the owners
of the parent (839) (245) (12,598)
Other comprehensive loss
Net exchange differences on translating
foreign operations 4 (307) (925) (1,340)
Total other comprehensive loss, net of
tax (307) (925) (1,340)
Total comprehensive loss (1,146) (1,170) (13,938)
Loss per share
- Basic and diluted 5 (0.50)p (0.15)p (7.57)p
CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION
As at 30 Restated As at 31
June 2012 Dec 2011
(unaudited) As at 30 (audited)
June 2011
(unaudited)
------------ ------------- ----------
Assets GBP'000s GBP'000s GBP'000s
Non-current assets
Property, plant and equipment 9,655 9,993 9,684
Goodwill - 7,581 -
Intangible assets 16,751 22,161 16,864
26,406 39,735 26,548
------------ ------------- ----------
Current assets
Inventories 116 447 111
Trade and other receivables 89 380 714
Fixed deposits 4,020 4,102 4,059
Cash and cash equivalents 1,101 1,348 1,188
5,326 6,277 6,072
------------ ------------- ----------
Total assets 31,732 46,012 32,620
------------ ------------- ----------
Liabilities
Current liabilities
Trade and other payables 165 683 373
Current income tax liabilities - 4 -
Borrowings 1,195 635 1,167
1,360 1,322 1,540
------------ ------------- ----------
Non-current liabilities
Borrowings 5,782 4,975 5,483
Deferred tax 4,355 5,540 4,216
10,137 10,515 9,699
------------ ------------- ----------
Total liabilities 11,497 11,837 11,239
------------ ------------- ----------
Net assets 20,235 34,175 21,381
============ ============= ==========
Equity
Share capital 1,664 1,664 1,664
Share premium account 12,089 12,089 12,089
Merger reserve 9,573 16,001 9,573
Translation reserve 4,829 8,700 5,136
Share-based payment reserve 66 225 66
Accumulated losses (7,986) (4,504) (7,147)
------------ ------------- ----------
Total equity 20,235 34,175 21,381
============ ============= ==========
CONSOLIDATED STATEMENT OF CHANGES IN EQUITY
Share-
Share based
Share premium Merger Translation payment Accumulated Total
capital account reserve reserve reserve losses equity
GBP000 GBP000 GBP000 GBP000 GBP000 GBP000 GBP000
At 1 January 2012 1,664 12,089 9,573 5,136 66 (7,147) 21,381
Loss for the period - - - - - (839) (839)
Translation reserve - - - (307) - - (307)
--------- --------- --------- ------------- -------- ------------- --------
Total comprehensive loss - - - (307) - (839) (1,146)
--------- --------- --------- ------------- -------- ------------- --------
At 30 June 2012 1,664 12,089 9,573 4,829 66 (7,986) 20,235
========= ========= ========= ============= ======== ============= ========
At 1 January 2011 1,664 12,089 16,001 9,625 225 (4,259) 35,345
Loss for the period - - - - - (245) (245)
Translation reserve - - - (925) - - (925)
--------- --------- --------- ------------- -------- ------------- --------
Total comprehensive loss - - - (925) - (245) (1,170)
--------- --------- --------- ------------- -------- ------------- --------
At 30 June 2011 1,664 12,089 16,001 8,700 225 (4,504) 34,175
========= ========= ========= ============= ======== ============= ========
At 1 January 2011 1,664 12,089 16,001 9,625 225 (4,259) 35,345
Loss for the year - - - - - (12,598) (12,598)
Translation reserve - - - (1,340) - - (1,340)
--------- --------- --------- ------------- -------- ------------- --------
Total comprehensive loss - - - (1,340) - (12,598) (13,938)
--------- --------- --------- ------------- -------- ------------- --------
Transactions with owners:
Lapse of options - - - - (133) 133 -
Share based payments credit - - - - (26) - (26)
Transfer of reserves in
respect of impairment loss - - (6,428) (3,149) - 9,577 -
--------- --------- --------- ------------- -------- ------------- --------
- - (6,428) (3,149) (159) 9,710 (26)
--------- --------- --------- ------------- -------- ------------- --------
At 31 December 2011 1,664 12,089 9,573 5,136 66 (7,147) 21,381
========= ========= ========= ============= ======== ============= ========
CONSOLIDATED STATEMENT OF CASH FLOWS
Note Six months Restated Year ended
ended 30 31 December
June 2012 2011
(unaudited) Six months (audited)
ended 30
June 2011
(unaudited)
GBP000s GBP000s GBP000s
Cash flow from operating activities
Cash generated from/(used in) operations 6 24 (445) (1,492)
Tax paid - - (5)
Net cash generated from/(used in) operating
activities 24 (445) (1,497)
------------ ------------ ------------
Cash flow from investing activities
Purchases of property, plant and equipment (264) (1,017) (1,028)
Proceeds from disposal of property,
plant and equipment - - 8
Interest received 42 47 80
Interest paid (274) - (223)
Net cash used in investing activities (496) (970) (1,163)
------------ ------------ ------------
Cash flows from financing activities
Proceeds from borrowings 390 1,025 2,114
Net cash generated from financing activities 390 1,025 2,114
------------ ------------ ------------
Net decrease in cash and cash equivalents (82) (390) (546)
Cash and cash equivalents at beginning
of period/year 1,188 1,750 1,750
Effect of exchange rate changes (5) (12) (16)
------------ ------------ ------------
Cash and cash equivalents at end of
period/year 1,101 1,348 1,188
============ ============ ============
NOTES TO THE UNAUDITED INTERIM FINANCIAL STATEMENTS
FOR THE SIX MONTHS ENDED 30 JUNE 2012
1 Basis of preparation
These unaudited interim condensed consolidated financial statements (the "interim financial statements") are for the six months ended 30 June 2012. They have been prepared using the recognition and measurement principles of IFRS (as adopted by the EU). IFRS include interpretations issued by the International Financial Reporting Interpretation Committee (IFRIC). They do not include all of the information required for full annual financial statements, and should be read in conjunction with the consolidated financial statements of the Group for the year ended 31 December 2011.
The interim financial statements have been prepared under the historical cost convention.. These interim financial statements have been prepared in accordance with the accounting policies as set out on pages 17 to 20 in the Group's consolidated financial statements for the year ended 31 December 2011. The accounting policies have been applied consistently throughout the Group for the purpose of preparation of the interim financial statements.
The financial information contained in these interim financial statements comprises the Group statement of financial position as at 30 June 2012, 30 June 2011 and 31 December 2011 and the Group statement of comprehensive income, the Group statement of cash flows and the Group statement of changes in equity for the half-years ended 30 June 2012 and 30 June 2011 and the year ended 31 December 2011.
The financial information set out on pages 3 to 6 is unaudited and does not constitute statutory accounts within the meaning of section 434 of the Companies Act 2006. The comparative numbers for the year ended 31 December 2011 have been extracted from the audited accounts which have been filed at Companies House and which carried an unqualified audit report with no statement under section 498 (2), (3) or (4) of the Companies Act 2006.
2 Segmental Information
Management has determined the operating segments based on the reports reviewed by The Board that are used to make strategic decisions.
Management has determined that the Group has one operating segment, which is the palm oil refining activity. The financial information contained in these financial statements therefore relates solely to this segment. The Group has produced revenue and does not have any customers representing more than 10% of the revenue. The Group's non-current assets consist of property, plant and equipment, goodwill and intangible assets, and are located entirely in Malaysia.
3 Income tax
There is no tax charge due to the losses arising in the period.
4 Net exchange differences on translating foreign operations
Income and expenditure for overseas subsidiaries are included based upon monthly average exchange rates to give a fair approximation to the transaction rate. Balance sheet items are included at the exchange rate at the balance sheet date. All other differences are included within the translation reserve, including related goodwill and intangible assets, which are translated at the rate ruling at the balance sheet date (30 June 2012 GBP1 = RM 4.97, at 30 June 2011 GBP1= RM 4.88 and at 31 December 2011 GBP1 = RM 4.90).
5 Loss per share
Six months Six months Year ended
ended 30 ended 30
June 2012 June 2011
(unaudited) (unaudited) 31 December
2011
(audited)
Loss attributable to equity shareholders GBP(839,000) GBP(245,000) GBP(12,598,000)
of the Company
Weighted average number of ordinary
shares in issue 166,445,000 166,445,000 166,445,000
Basic loss per share in pence (0.50)p (0.15)p (7.57)p
The impact of options and warrants on the loss per share is anti-dilutive and therefore no diluted loss per share figures have been included.
6 Cash generated from/(used in) operations
Six months Six months Year ended
ended 30 ended 30
June 2012 June 2011
(unaudited) (unaudited) 31 December
2011
(audited)
GBP'000s GBP'000s GBP'000s
Operating loss (607) (292) (13,704)
Adjustments for:
Depreciation 200 20 221
Impairment loss on other receivables 252
Impairment loss on goodwill - - 7,480
Impairment loss on intangible assets - - 5,000
Loss on disposal of property, plant and
equipment - - 16
Unrealised loss on foreign exchange - - 1
Share based payments credit - - (26)
Changes in working capital:
- Inventories (6) (420) (84)
- Trade and other receivables 619 (79) (669)
- Trade and other payables (205) 328 21
Effect on exchange rate changes 23 (2) -
------------ ------------ ------------
Cash inflow/(outflow) from operations 24 (445) (1,492)
============ ============ ============
7 Dividend
The directors do not recommend the payment of a dividend.
8 Contingencies
In the matter of dispute between Zurex, a subsidiary of Biofutures International plc and JJ-Lurgi, in connection with the contract between them dated 26 January 2007 for the supply of components for the construction of a palm oil biodiesel plant, the decision of the Arbitrator was received in February 2012.
The Arbitrator dismissed both Zurex's and JJ-Lurgi's claims. Since then, the parties have settled their dispute agreeing that Zurex will acquire components from JJ-Lurgi for RM800,000, payable by 12 equal monthly installments. With this final agreement not being reached by 30 June 2012, no provision has been made in these interim financial statements.
9 Restatement of comparative figures
The 30 June 2011 comparatives in the interim financial statements have been restated following a reclassification of fixed deposits pledged as security from cash equivalents to non-cash equivalents in order to be consistent with the approach adopted in the consolidated financial statements of the Group for the year ended 31 December 2011.
The effect of foreign exchange rate changes arising as a result of the reclassification has been reflected accordingly.
The following comparative figures in the interim financial statements have been reclassified:
Previously
reported As restated
GBP'000s GBP'000s
Condensed Consolidated Statement of Financial
Position
Fixed deposit - 4,102
Cash and cash equivalents 5,450 1,348
========== =============
Consolidated Statement of Cash Flows
Cash used in operations (442) (445)
Proceeds from borrowings 898 1,025
Net decrease in cash and cash equivalents (514) (390)
Cash and cash equivalents at beginning
of period 5,966 1,750
Effects of exchange rate changes (2) (12)
Cash and cash equivalents at end of period 5,450 1,348
========== =============
10 Availability of half yearly report
The Company's half yearly report will be available in soft copy from the investors' section of the Company's website (www.biofuturesplc.com).
This information is provided by RNS
The company news service from the London Stock Exchange
END
IR ZMGZLKVRGZZM
1 Year Biofutures Chart |
1 Month Biofutures Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
